ABIVAX S.A. (ABVX)
Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
BXP to Release Second Quarter 2026 Financial Results on July 28, 2026
BGC Group to Report Second Quarter 2026 Financial Results on July 30, 2026
TFI International publiera ses résultats du deuxième trimestre de 2026
Global Partners LP Announces Full Redemption of Series B Fixed Rate Cumulative Redeemable Perpetual Preferred Units
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database
Results of Operations for the Three Months Ended March 31, 2026 - American Overseas Group Limited Announces Net Income Of $3.3 Million For the Three Months Ended March 31, 2026
Ampco-Pittsburgh Corporation Joins US small-cap Russell 2000® Index
American Coastal Insurance Corporation Announces the Completion of $14.4 Million in Common Stock Share Repurchases
Synchrony Announces Executive Leadership Changes to Advance Digital Growth, Customer Experience and AI Momentum